Funded Tech Companies
Elicio Therapeutics
Elicio Therapeutics is a leading biopharmaceutical company, based in Cambridge. Venture capital investment was provided by private investors, Clal Biotechnology Industries and EFung Capital.
Company Overview
Company Name
Elicio Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Kendall Sq. Building 1400 West 14303
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
Elicio, based in Cambridge MA, is committed to transforming the lives of patients and their families by re-engineering the body's immune response to defeat cancer. By combining expertise in materials science and immunology, Elicio is engineering potent vaccines and immuno-therapies for an array of aggressive cancers.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/18/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Connelly
Chief Medical Officer
Christopher Haqq
VP - Bus. Development
Charles Chase
VP - Bus. Development
Annette Matthies
VP - Operations
Michael DiVecchia
VP - Operations
Esther Welkowsky
VP - R & D
Peter DeMuth
VP - Regulatory Affairs
Nicole Hsu
Company Investors
- Clal Biotechnology Industries
- EFung Capital
- Livzon Mabpharm
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs